Daiwa Securities Group
KZR

Daiwa Securities Group’s Kezar Life Sciences KZR Stock Holding History

Daiwa Securities Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28
Closed – – 1360
2023
Q3 		$0 Hold
28
– – ﹤0.01% 1315
2023
Q2 		$1K Hold
28
– – ﹤0.01% 1281
2023
Q1 		$1K Hold
28
– – ﹤0.01% 1261
2022
Q4 		$2K Buy
28
+13
+87% +$964 ﹤0.01% 1229
2022
Q3 		$1K Hold
15
– – ﹤0.01% 1298
2022
Q2 		$1K Hold
15
– – ﹤0.01% 1298
2022
Q1 		$2K Buy
15
+6
+67% +$861 ﹤0.01% 1257
2021
Q4 		$1K Hold
9
– – ﹤0.01% 1344
2021
Q3 		$1K Hold
9
– – ﹤0.01% 1274
2021
Q2 		$0 Hold
9
– – ﹤0.01% 1276
2021
Q1 		$1K Hold
9
– – ﹤0.01% 1209
2020
Q4 		$0 Buy
+9
New +$501 ﹤0.01% 1278

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's KZR Position: Q4 2023 in Review

Daiwa Securities Group sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 28 shares.

Daiwa Securities Group first reported a position in KZR in Q4 2020 and held it in 12 quarters. The position peaked at $2K in Q4 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Daiwa Securities Group reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 28 Kezar Life Sciences shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Kezar Life Sciences in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's Kezar Life Sciences position peaked at $2K in Q4 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.